Pyrrolidine dithiocarbamate reverses Bcl-xL-mediated apoptotic resistance to doxorubicin by inducing paraptosis-Reference-Cited by-同舟云学术

Pyrrolidine dithiocarbamate reverses Bcl-xL-mediated apoptotic resistance to doxorubicin by inducing paraptosis

Published:2018-01-10 Issue:3 Volume:39 Page:458-470
ISSN:0143-3334
Container-title:Carcinogenesis
language:en
Short-container-title:

Author:

Park Seok Soon¹²³,Lee Dong Min¹²⁴,Lim Jun Hee⁴,Lee Dongjoo⁵,Park Sang Jun⁶,Kim Hwan Myung⁶,Sohn Seonghyang⁷,Yoon Gyesoon¹²,Eom Young Woo⁸,Jeong Seong-Yun³,Choi Eun Kyung⁹,Choi Kyeong Sook¹²⁴

Affiliation:

1. Department of Biochemistry, Ajou University School of Medicine, Suwon, Korea

2. Department of Biomedical Sciences, Ajou Graduate School, Suwon, Korea

3. Asan Institute for Life Sciences, Department of Convergence Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

4. Genomic Instability Center, Ajou University School of Medicine, Suwon, Korea

5. Department of Pharmacy, Ajou University, Suwon, Korea

6. Department of Energy Systems Research, Ajou University, Suwon, Korea

7. Department of Microbiology, Ajou University, Suwon, Korea

8. Cell therapy and Tissue Engineering Center, Wonju College of Medicine, Yonsei University, Wonju, Korea

9. Center for Advancing Cancer Therapeutics, Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea

Funder

National Research Foundation of Korea

Ministry of Health and Welfare

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,General Medicine

Link

http://academic.oup.com/carcin/article-pdf/39/3/458/24273474/bgy003.pdf

Reference55 articles.

1. Epidemiology of viral hepatitis and hepatocellular carcinoma;El-Serag;Gastroenterology,2012

2. Treatment modalities for hepatocellular carcinoma;Hung;Curr. Cancer Drug Targets,2005